JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naruke, T.
Right arrow Articles by Suemasu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naruke, T.
Right arrow Articles by Suemasu, K.

The Journal of Thoracic and Cardiovascular Surgery, Vol 96, 440-447, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Prognosis and survival in resected lung carcinoma based on the new international staging system [published erratum appears in J Thorac Cardiovasc Surg 1989 Mar;97(3):350]

T Naruke, T Goya, R Tsuchiya and K Suemasu
Department of Surgery, National Cancer Center Hospital, Tokyo, Japan.

A new TNM staging system was proposed and the previous system has been revised recently. To evaluate the new TNM staging system for lung cancer, we analyzed records of 1737 patients who underwent pulmonary resection at the National Cancer Center Hospital, Tokyo. With regard to clinical stages, three patients had occult carcinoma; 821 patients had stage I disease; 248 patients, stage II; 465 patients, stage IIIA; 82 patients, stage IIIB; and 118 patients, stage IV. The 5-year survival rates for the respective stages were 50.1% for stage I, 31.2% for stage II, 20.2% for stage IIIA, 5.1% for stage IIIB, and 7.9% for stage IV. In terms of postoperative stages, four patients were classified in stage 0, 536 in stage I, 221 in stage II, 559 in stage IIIA, 159 in stage IIIB, and 258 in stage IV. The 5-year survival rates were as follows: stage I, 65.0%; stage II, 42.9%; stage IIIA, 22.2%; stage IIIB, 5.6%; and stage IV, 7.5%. In both the clinical stage and the postoperative stage, there were significant prognostic differences between stage I and stage II, stage II and stage IIIA, and stage IIIA and stage IIIB, but there was no significant difference in 5-year survival rates between stage IIIB and stage IV.


This article has been cited by other articles:


Home page
ChestHome page
R. Maeda, J. Yoshida, G. Ishii, T. Hishida, M. Nishimura, and K. Nagai
Risk Factors for Tumor Recurrence in Patients With Early-Stage (Stage I and II) Non-small Cell Lung Cancer: Patient Selection Criteria for Adjuvant Chemotherapy According to the Seventh Edition TNM Classification
Chest, December 1, 2011; 140(6): 1494 - 1502.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
P. Mordant, A. Arame, C. Foucault, A. Dujon, F. Le Pimpec Barthes, and M. Riquet
Surgery for metastatic pleural extension of non-small-cell lung cancer
Eur J Cardiothorac Surg, December 1, 2011; 40(6): 1444 - 1449.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. E. Darling, M. S. Allen, P. A. Decker, K. Ballman, R. A. Malthaner, R. I. Inculet, D. R. Jones, R. J. McKenna, R. J. Landreneau, and J. B. Putnam Jr
Number of Lymph Nodes Harvested From a Mediastinal Lymphadenectomy: Results of the Randomized, Prospective American College of Surgeons Oncology Group Z0030 Trial
Chest, May 1, 2011; 139(5): 1124 - 1129.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
M. Casiraghi, L. L. Travaini, P. Maisonneuve, A. Tessitore, D. Brambilla, B. G. Agoglia, J. Guarize, and L. Spaggiari
Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?
Eur J Cardiothorac Surg, April 1, 2011; 39(4): e38 - e43.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. E. Dunlap, J. M. Larner, P. W. Read, B. D. Kozower, C. L. Lau, K. Sheng, and D. R. Jones
Size matters: A comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)
J. Thorac. Cardiovasc. Surg., September 1, 2010; 140(3): 583 - 589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Faoro, P. A. Singleton, G. M. Cervantes, F. E. Lennon, N. W. Choong, R. Kanteti, B. D. Ferguson, A. N. Husain, M. S. Tretiakova, N. Ramnath, et al.
EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation
J. Biol. Chem., June 11, 2010; 285(24): 18575 - 18585.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
W. G. Hocking, P. Hu, M. M. Oken, S. D. Winslow, P. A. Kvale, P. C. Prorok, L. R. Ragard, J. Commins, D. A. Lynch, G. L. Andriole, et al.
Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
J Natl Cancer Inst, May 19, 2010; 102(10): 722 - 731.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. S. Nair, P. G. Barnett, L. Ananth, M. K. Gould, and for the Veterans Affairs Solitary Nodule Accuracy
PET Scan 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients With Resected Clinical Stage IA Non-small Cell Lung Cancer
Chest, May 1, 2010; 137(5): 1150 - 1156.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
M. Suzuki, S. Yoshida, H. Tamura, H. Wada, Y. Moriya, H. Hoshino, K. Shibuya, and I. Yoshino
Applicability of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers
Eur J Cardiothorac Surg, December 1, 2009; 36(6): 1031 - 1036.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. Vergani, F. Varoli, L. Despini, S. Harari, E. Mozzi, and G. Roviaro
Routine surgical videothoracoscopy as the first step of the planned resection for lung cancer
J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1206 - 1212.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. S. Kassis, A. A. Vaporciyan, S. G. Swisher, A. M. Correa, B. N. Bekele, J. J. Erasmus, W. L. Hofstetter, R. Komaki, R. J. Mehran, C. A. Moran, et al.
Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population
J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 412 - 418.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
B. Witte, A. Messerschmidt, H. Hillebrand, S. Gross, M. Wolf, E. Kriegel, W. Neumeister, and M. Hurtgen
Combined videothoracoscopic and videomediastinoscopic approach improves radicality of minimally invasive mediastinal lymphadenectomy for early stage lung carcinoma
Eur J Cardiothorac Surg, February 1, 2009; 35(2): 343 - 347.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
F. M. A. Melfi, M. Lucchi, F. Davini, A. Viti, G. Fontanini, L. Boldrini, G. Boni, and A. Mussi
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction
Eur J Cardiothorac Surg, July 1, 2008; 34(1): 181 - 186.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
G. Leschber, D. Sperling, W. Klemm, and J. Merk
Does video-mediastinoscopy improve the results of conventional mediastinoscopy?
Eur J Cardiothorac Surg, February 1, 2008; 33(2): 289 - 293.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. K. Lau, P. C. Boutros, M. Pintilie, F. H. Blackhall, C.-Q. Zhu, D. Strumpf, M. R. Johnston, G. Darling, S. Keshavjee, T. K. Waddell, et al.
Three-Gene Prognostic Classifier for Early-Stage Non Small-Cell Lung Cancer
J. Clin. Oncol., December 10, 2007; 25(35): 5562 - 5569.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. Jeremic
Low Incidence of Isolated Nodal Failures After Involved-Field Radiation Therapy for Non Small-Cell Lung Cancer: Blinded by the Light?
J. Clin. Oncol., December 10, 2007; 25(35): 5543 - 5545.
[Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
O. Rena, L. Carsana, S. Cristina, E. Papalia, F. Massera, L. Errico, C. Bozzola, and C. Casadio
Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance
Eur J Cardiothorac Surg, December 1, 2007; 32(6): 863 - 867.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Y. Chang, S. J. Mentzer, Y. L. Colson, P. A. Linden, M. T. Jaklitsch, S. R. Lipsitz, and D. J. Sugarbaker
Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 850 - 856.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Rao, R. A. Sayeed, S. Tomaszek, S. Fischer, S. Keshavjee, and G. E. Darling
Prognostic Factors in Resected Satellite Nodule T4 Non-Small Cell Lung Cancer
Ann. Thorac. Surg., September 1, 2007; 84(3): 934 - 939.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. A. Whitson, S. S. Groth, and M. A. Maddaus
Surgical Assessment and Intraoperative Management of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer
Ann. Thorac. Surg., September 1, 2007; 84(3): 1059 - 1065.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. Tsuchiya, S. Hashizume, S. Akamine, M. Muraoka, S. Honda, K. Tsuji, S. Urabe, T. Hayashi, N. Yamasaki, and T. Nagayasu
Upstaging by Vessel Invasion Improves the Pathology Staging System of Non-Small Cell Lung Cancer
Chest, July 1, 2007; 132(1): 170 - 177.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Witte, M. Wolf, M. Huertgen, and H. Toomes
Video-Assisted Mediastinoscopic Surgery: Clinical Feasibility and Accuracy of Mediastinal Lymph Node Staging
Ann. Thorac. Surg., November 1, 2006; 82(5): 1821 - 1827.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. Timmerman, R. McGarry, C. Yiannoutsos, L. Papiez, K. Tudor, J. DeLuca, M. Ewing, R. Abdulrahman, C. DesRosiers, M. Williams, et al.
Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer
J. Clin. Oncol., October 20, 2006; 24(30): 4833 - 4839.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Raponi, Y. Zhang, J. Yu, G. Chen, G. Lee, J. M.G. Taylor, J. MacDonald, D. Thomas, C. Moskaluk, Y. Wang, et al.
Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
Cancer Res., August 1, 2006; 66(15): 7466 - 7472.
[Abstract] [Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
R. P. Petersen and D. H. Harpole Jr.
Computed Tomography Screening for the Early Detection of Lung Cancer
J Natl Compr Canc Netw, July 1, 2006; 4(6): 591 - 594.
[Abstract] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M.-F. Tsai, C.-C. Wang, G.-C. Chang, C.-Y. Chen, H.-Y. Chen, C.-L. Cheng, Y.-P. Yang, C.-Y. Wu, F.-Y. Shih, C.-C. Liu, et al.
A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
J Natl Cancer Inst, June 21, 2006; 98(12): 825 - 838.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Guo, Y. Ma, R. Ward, V. Castranova, X. Shi, and Y. Qian
Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma.
Clin. Cancer Res., June 1, 2006; 12(11): 3344 - 3354.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. M. Oken, P. M. Marcus, P. Hu, T. M. Beck, W. Hocking, P. A. Kvale, J. Cordes, T. L. Riley, S. D. Winslow, S. Peace, et al.
Baseline Chest Radiograph for Lung Cancer Detection in the Randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
J Natl Cancer Inst, December 21, 2005; 97(24): 1832 - 1839.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. Jeremic, B. Milicic, L. Acimovic, and S. Milisavljevic
Concurrent Hyperfractionated Radiotherapy and Low-Dose Daily Carboplatin/Paclitaxel in Patients With Early-Stage (I/II) Non-Small-Cell Lung Cancer: Long-Term Results of a Phase II Study
J. Clin. Oncol., October 1, 2005; 23(28): 6873 - 6880.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
T. Nakagawa, N. Okumura, K. Miyoshi, T. Matsuoka, and K. Kameyama
Prognostic factors in patients with ipsilateral pulmonary metastasis from non-small cell lung cancer
Eur J Cardiothorac Surg, October 1, 2005; 28(4): 635 - 639.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Donati, L. Boldrini, M. Dell'Omodarme, M. C. Prati, P. Faviana, T. Camacci, M. Lucchi, A. Mussi, M. Santoro, F. Basolo, et al.
Osteopontin Expression and Prognostic Significance in Non-Small Cell Lung Cancer
Clin. Cancer Res., September 15, 2005; 11(18): 6459 - 6465.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Xi, J. Lyons-Weiler, M. C. Coello, X. Huang, W. E. Gooding, J. D. Luketich, and T. E. Godfrey
Prediction of Lymph Node Metastasis by Analysis of Gene Expression Profiles in Primary Lung Adenocarcinomas
Clin. Cancer Res., June 1, 2005; 11(11): 4128 - 4135.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Ishikawa, T. Nakagawa, R. Miyahara, Y. Kawano, K. Takenaka, K. Yanagihara, Y. Otake, H. Katakura, H. Wada, and F. Tanaka
Expression of MDA-7/IL-24 and Its Clinical Significance in Resected Non-Small Cell Lung Cancer
Clin. Cancer Res., February 1, 2005; 11(3): 1198 - 1202.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Chen, K. Takenaka, E. Ogawa, K. Yanagihara, Y. Otake, H. Wada, and F. Tanaka
Flt-4-Positive Endothelial Cell Density and Its Clinical Significance in Non-Small Cell Lung Cancer
Clin. Cancer Res., December 15, 2004; 10(24): 8548 - 8553.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
N. Lorent, P. De Leyn, Y. Lievens, E. Verbeken, K. Nackaerts, C. Dooms, D. Van Raemdonck, B. Anrys, J. Vansteenkiste, and The Leuven Lung Cancer Group
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience
Ann. Onc., November 1, 2004; 15(11): 1645 - 1653.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Ikeda, J. Maeda, K. Yashima, M. Tsuboi, H. Kato, S. Akada, and S. Okada
A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter
Ann. Thorac. Surg., September 1, 2004; 78(3): 1011 - 1016.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. Roviaro, F. Varoli, C. Vergani, O. Nucca, M. Maciocco, and F. Grignani
Long-term Survival After Videothoracoscopic Lobectomy for Stage I Lung Cancer
Chest, September 1, 2004; 126(3): 725 - 732.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Halter, A. K. Buck, H. Schirrmeister, I. Wurziger, F. Liewald, G. Glatting, B. Neumaier, L. Sunder-Plassmann, S. N. Reske, and M. Hetzel
[18F] 3-deoxy-3'-fluorothymidine positron emission tomography: Alternative or diagnostic adjunct to 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1093 - 1099.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Inoue, N. Sawabata, S.-i. Takeda, M. Ohta, Y. Ohno, and H. Maeda
Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe
J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1100 - 1106.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. G. Byrne, M. Leacche, A. K. Agnihotri, S. Paul, R. Bueno, D. J. Mathisen, and D. J. Sugarbaker
The Use of Cardiopulmonary Bypass During Resection of Locally Advanced Thoracic Malignancies: A 10-Year Two-Center Experience
Chest, April 1, 2004; 125(4): 1581 - 1586.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
A. Sayar, A. Turna, A. Kilicgun, O. Solak, N. Urerurer, and A. Gurses
Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung
Eur J Cardiothorac Surg, March 1, 2004; 25(3): 434 - 438.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. V. Brock, M. P. Kim, C. M. Hooker, A. J. Alberg, M. M. Jordan, C. M. Roig, L. Xu, and S. C. Yang
Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: a 22-year experience
Ann. Thorac. Surg., January 1, 2004; 77(1): 271 - 277.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Chen, T. G. Gharib, H. Wang, C.-C. Huang, R. Kuick, D. G. Thomas, K. A. Shedden, D. E. Misek, J. M. G. Taylor, T. J. Giordano, et al.
Protein profiles associated with survival in lung adenocarcinoma
PNAS, November 11, 2003; 100(23): 13537 - 13542.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Timmerman, L. Papiez, R. McGarry, L. Likes, C. DesRosiers, S. Frost, and M. Williams
Extracranial Stereotactic Radioablation: Results of a Phase I Study in Medically Inoperable Stage I Non-small Cell Lung Cancer
Chest, November 1, 2003; 124(5): 1946 - 1955.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
G. Leschber, G. Holinka, and A. Linder
Video-assisted mediastinoscopic lymphadenectomy (VAMLA) - a method for systematic mediastinal lymphnode dissection
Eur J Cardiothorac Surg, August 1, 2003; 24(2): 192 - 195.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Marra, L. Hillejan, G. Zaboura, T. Fujimoto, D. Greschuchna, and G. Stamatis
Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis
J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 543 - 553.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Nagai, R. Tsuchiya, T. Mori, H. Tada, Y. Ichinose, T. Koike, and H. Kato
A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209)
J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 254 - 260.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
F. M. A. Melfi, A. Chella, G. F. Menconi, F. Givigliano, G. Boni, G. Mariani, P. Sbragia, and C. A. Angeletti
Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer
Eur J Cardiothorac Surg, February 1, 2003; 23(2): 214 - 220.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
F. Patane, A. Verzini, E. Zingarelli, and M. di Summa
Simultaneous operation for cardiac disease and lung cancer
Interact CardioVasc Thorac Surg, December 1, 2002; 1(2): 69 - 71.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. T. Winer-Muram, S. G. Jennings, R. D. Tarver, A. M. Aisen, M. Tann, D. J. Conces, and C. A. Meyer
Volumetric Growth Rate of Stage I Lung Cancer prior to Treatment: Serial CT Scanning
Radiology, June 1, 2002; 223(3): 798 - 805.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Sok, M. Sentjurc, M. Schara, J. Stare, and T. Rott
Cell membrane fluidity and prognosis of lung cancer
Ann. Thorac. Surg., May 1, 2002; 73(5): 1567 - 1571.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Sawabata, A. Matsumura, A. Motohiro, Y. Osaka, K. Gennga, S. Fukai, and T. Mori
Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: is tumor resection beneficial for prognosis?
Ann. Thorac. Surg., February 1, 2002; 73(2): 412 - 415.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Deslauriers
Current surgical treatment of nonsmall cell lung cancer 2001
Eur. Respir. J., February 1, 2002; 19(35_suppl): 61S - 70s.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. F. Esnaola, S. N. Lazarides, S. J. Mentzer, and K. M. Kuntz
Outcomes and Cost-Effectiveness of Alternative Staging Strategies for Non-Small-Cell Lung Cancer
J. Clin. Oncol., January 1, 2002; 20(1): 263 - 273.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Higashi, Y. Ueda, Y. Arisaka, T. Sakuma, Y. Nambu, M. Oguchi, H. Seki, S. Taki, H. Tonami, and I. Yamamoto
18F-FDG Uptake as a Biologic Prognostic Factor for Recurrence in Patients with Surgically Resected Non-Small Cell Lung Cancer
J. Nucl. Med., January 1, 2002; 43(1): 39 - 45.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Usadel, J. Brabender, K. D. Danenberg, C. Jeronimo, S. Harden, J. Engles, P. V. Danenberg, S. Yang, and D. Sidransky
Quantitative Adenomatous Polyposis Coli Promoter Methylation Analysis in Tumor Tissue, Serum, and Plasma DNA of Patients with Lung Cancer
Cancer Res., January 1, 2002; 62(2): 371 - 375.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
A. Bernard, O. Bouchot, O. Hagry, and J. P. Favre
Risk analysis and long-term survival in patients undergoing resection of T4 lung cancer
Eur J Cardiothorac Surg, August 1, 2001; 20(2): 344 - 349.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Naruke, R. Tsuchiya, H. Kondo, and H. Asamura
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience
Ann. Thorac. Surg., June 1, 2001; 71(6): 1759 - 1764.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
I. Takanami, K. Takeuchi, and M. Giga
The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma
J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1058 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. R. Khuri, H. Wu, J. J. Lee, B. L. Kemp, R. Lotan, S. M. Lippman, L. Feng, W. K. Hong, and X.-C. Xu
Cyclooxygenase-2 Overexpression Is a Marker of Poor Prognosis in Stage I Non-Small Cell Lung Cancer
Clin. Cancer Res., April 1, 2001; 7(4): 861 - 867.
[Abstract] [Full Text]


Home page
JCOHome page
B. Jeremic, Y. Shibamoto, L. Acimovic, N. Nikolic, A. Dagovic, J. Aleksandrovic, and G. Radosavljevic-Asic
Second Cancers Occurring in Patients With Early Stage Non-Small-Cell Lung Cancer Treated With Chest Radiation Therapy Alone
J. Clin. Oncol., February 15, 2001; 19(4): 1056 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer
Ann. Thorac. Surg., February 1, 2001; 71(2): 425 - 433.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Bueno, W. G. Richards, S. J. Swanson, M. T. Jaklitsch, J. M. Lukanich, S. J. Mentzer, and D. J. Sugarbaker
Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival
Ann. Thorac. Surg., December 1, 2000; 70(6): 1826 - 1831.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Asamura, K. Suzuki, H. Kondo, and R. Tsuchiya
Where is the boundary between N1 and N2 stations in lung cancer?
Ann. Thorac. Surg., December 1, 2000; 70(6): 1839 - 1846.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Hashimoto, Y. Kobayashi, Y. Ishikawa, S. Tsuchiya, S. Okumura, K. Nakagawa, Y. Tokuchi, M. Hayashi, K. Nishida, S.-i. Hayashi, et al.
Prognostic Value of Genetically Diagnosed Lymph Node Micrometastasis in Non-Small Cell Lung Carcinoma Cases
Cancer Res., November 1, 2000; 60(22): 6472 - 6478.
[Abstract] [Full Text]


Home page
Eur J Cardiothorac SurgHome page
A. Chapelier, E. Fadel, P. Macchiarini, B. Lenot, F. Le Roy Ladurie, J. Cerrina, and P. Dartevelle
Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall
Eur J Cardiothorac Surg, November 1, 2000; 18(5): 513 - 518.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Yokoi, R. Tsuchiya, T. Mori, K. Nagai, T. Furukawa, S. Fujimura, K. Nakagawa, and Y. Ichinose
Results of surgical treatment of lung cancer involving the diaphragm
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 799 - 805.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. R. Khuri, R. Lotan, B. L. Kemp, S. M. Lippman, H. Wu, L. Feng, J. J. Lee, C. S. Cooksley, B. Parr, E. Chang, et al.
Retinoic Acid Receptor-Beta as a Prognostic Indicator in Stage I Non-Small-Cell Lung Cancer
J. Clin. Oncol., August 15, 2000; 18(15): 2798 - 2804.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. J. Liptay, G. A. Masters, D. J. Winchester, B. L. Edelman, B. J. Garrido, T. R. Hirschtritt, R. M. Perlman, and W. A. Fry
Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer
Ann. Thorac. Surg., August 1, 2000; 70(2): 384 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Jassem, J. Skokowski, R. Dziadziuszko, E. Jassem, A. Szymanowska, W. Rzyman, and A. Roszkiewicz
RESULTS OF SURGICAL TREATMENT OF NON-SMALL CELL LUNG CANCER: VALIDATION OF THE NEW POSTOPERATIVE PATHOLOGIC TNM CLASSIFICATION
J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1141 - 1146.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Ferretti, G. Curigliano, U. Pastorino, A. Cittadini, G. Flamini, M. G. Calabro, Tommaso De Pas, L. Orlando, M. Mandala, M. Colleoni, et al.
Detection by Denaturant Gradient Gel Electrophoresis of Tumor-specific Mutations in Biopsies and Relative Bronchoalveolar Lavage Fluid from Resectable Non-Small Cell Lung Cancer
Clin. Cancer Res., June 1, 2000; 6(6): 2393 - 2400.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
T. Niki, S. Iba, M. Tokunou, T. Yamada, Y. Matsuno, and S. Hirohashi
Expression of Vascular Endothelial Growth Factors A, B, C, and D and Their Relationships to Lymph Node Status in Lung Adenocarcinoma
Clin. Cancer Res., June 1, 2000; 6(6): 2431 - 2439.
[Abstract] [Full Text]


Home page
ChestHome page
J. Deslauriers and J. Gregoire
Surgical Therapy of Early Non-Small Cell Lung Cancer
Chest, April 1, 2000; 117(2009): 104S - 109S.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. S. Herbst, S. Yano, H. Kuniyasu, F. R. Khuri, C. D. Bucana, F. Guo, D. Liu, B. Kemp, J. J. Lee, W. K. Hong, et al.
Differential Expression of E-cadherin and Type IV Collagenase Genes Predicts Outcome in Patients with Stage I Non-Small Cell Lung Carcinoma
Clin. Cancer Res., March 1, 2000; 6(3): 790 - 797.
[Abstract] [Full Text]


Home page
Am. J. Roentgenol.Home page
E. F. Patz Jr., J. Connolly, and J. Herndon
Prognostic Value of Thoracic FDG PET Imaging After Treatment for Non-Small Cell Lung Cancer
Am. J. Roentgenol., March 1, 2000; 174(3): 769 - 774.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Th. M. van Rens, A. Brutel de la Riviere, H. R. J. Elbers, and J. M. M. van den Bosch
Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA
Chest, February 1, 2000; 117(2): 374 - 379.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Blaes, M. Klotz, H. Huwer, U. Straub, G. Kalweit, K. Schimrigk, and H.-J. Schafers
Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer
Ann. Thorac. Surg., January 1, 2000; 69(1): 254 - 258.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. H. Park, Y. M. Shim, H. J. Baek, M.-S. Kim, D. H. Choe, K.-J. Cho, C.-T. Lee, and J. I. Zo
Postoperative adjuvant therapy for stage II non-small-cell lung cancer
Ann. Thorac. Surg., November 1, 1999; 68(5): 1821 - 1826.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Hashimoto, Y. Tokuchi, M. Hayashi, Y. Kobayashi, K. Nishida, S.-i. Hayashi, Y. Ishikawa, S. Tsuchiya, K. Nakagawa, J.-i. Hayashi, et al.
p53 Null Mutations Undetected by Immunohistochemical Staining Predict a Poor Outcome with Early-Stage Non-Small Cell Lung Carcinomas
Cancer Res., November 1, 1999; 59(21): 5572 - 5577.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. R. Roberts, M. G. Blum, R. Arildsen, D. C. Drinkwater Jr, K. R. Christian, T. A. Powers, and W. H. Merrill
Prospective comparison of radiologic, thoracoscopic, and pathologic staging in patients with early non-small cell lung cancer
Ann. Thorac. Surg., October 1, 1999; 68(4): 1154 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. E. Sawyer, J. A. Bonner, P. M. Gould, R. L. Foote, C. Deschamps, C. M. Lange, and H. Li
Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma
Ann. Thorac. Surg., October 1, 1999; 68(4): 1171 - 1176.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and R. Nakai
Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis
Ann. Thorac. Surg., August 1, 1999; 68(2): 326 - 330.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
I. Yoshino, R. Nakanishi, T. Osaki, M. Takenoyama, S. Taga, T. Hanagiri, and K. Yasumoto
Unfavorable Prognosis of Patients With Stage II Non-small Cell Lung Cancer Associated With Macroscopic Nodal Metastases
Chest, July 1, 1999; 116(1): 144 - 149.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Riquet, D. Manac'h, F. Le Pimpec-Barthes, A. Dujon, and A. Chehab
Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung
Ann. Thorac. Surg., June 1, 1999; 67(6): 1572 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. van Velzen, A. Brutel de la Riviere, H. J.J. Elbers, J.-W. J. Lammers, and J. M.M. van den Bosch
Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma
Ann. Thorac. Surg., April 1, 1999; 67(4): 903 - 907.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Asamura, M. Ando, Y. Matsuno, and Y. Shimosato
Histopathologic Prognostic Factors in Resected Adenocarcinomas: Is Nuclear DNA Content Prognostic?
Chest, April 1, 1999; 115(4): 1018 - 1024.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. A. Ahrendt, J. T. Chow, L.-H. Xu, S. C. Yang, C. F. Eisenberger, M. Esteller, J. G. Herman, L. Wu, P. A. Decker, J. Jen, et al.
Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung Cancer
J Natl Cancer Inst, February 17, 1999; 91(4): 332 - 339.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. A. Rendina, F. Venuta, T. D. Giacomo, A. M. Ciccone, G. Ruvolo, G. F. Coloni, C. Ricci, and S. G. A. Patterson
INDUCTION CHEMOTHERAPY FOR T4 CENTRALLY LOCATED NON-SMALL CELL LUNG CANCER
J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 225 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. J. M. Chan, MB, U. Pastorino, MD, and P. Goldstraw, FRCS
SYSTEMATIC NODAL DISSECTION IN THE INTRATHORACIC STAGING OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 246 - 251.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Esteller, M. Sanchez-Cespedes, R. Rosell, D. Sidransky, S. B. Baylin, and J. G. Herman
Detection of Aberrant Promoter Hypermethylation of Tumor Suppressor Genes in Serum DNA from Non-Small Cell Lung Cancer Patients
Cancer Res., January 1, 1999; 59(1): 67 - 70.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. S. Leong, C. M. Rocha Lima, C. A. Sherman, and M. R. Green
The 1997 International Staging System for Non-Small Cell Lung Cancer: Have All the Issues Been Addressed?
Chest, January 1, 1999; 115(1): 242 - 248.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B. E. Johnson
Second Lung Cancers in Patients After Treatment for an Initial Lung Cancer
J Natl Cancer Inst, September 16, 1998; 90(18): 1335 - 1345.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Inoue, M. Sato, S. Fujimura, A. Sakurada, S. Takahashi, K. Usuda, T. Kondo, T. Tanita, M. Handa, Y. Saito, et al.
Prognostic assessment of 1310 patients with non-small-cell lungcancer who underwent complete resection from 1980 to 1993
J. Thorac. Cardiovasc. Surg., September 1, 1998; 116(3): 407 - 411.
[Abstract] [Full Text]


Home page
Eur J Cardiothorac SurgHome page
F. Tanaka, R. Miyahara, Y. Ohtake, K. Yanagihara, T. Fukuse, S. Hitomi, and H. Wada
Advantage of post-operative oral administration of UFT (Tegafur and Uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC)
Eur J Cardiothorac Surg, September 1, 1998; 14(3): 256 - 262.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
S. Pagni, A. McKelvey, C. Riordan, J. A. Federico, and R. B. Ponn
Pulmonary resection for malignancy in the elderly: is age still a risk factor?
Eur J Cardiothorac Surg, July 1, 1998; 14(1): 40 - 45.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
M. H. D. Danton, V. A. Anikin, K. G. McManus, J. A. McGuigan, and G. Campalani
Simultaneous cardiac surgery with pulmonary resection: presentation of series and review of literature
Eur J Cardiothorac Surg, June 1, 1998; 13(6): 667 - 672.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
S. George, M. J. Schell, F. C. Detterbeck, and M. A. Socinski
Adjuvant Chemotherapy for Resected Non-Small Cell Carcinoma of the Lung: Why We Still Don't Know
Oncologist, February 1, 1998; 3(1): 35 - 44.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
Y. Lacasse, H. C. Bucher, E. Wong, L. Griffith, S. Walter, R. J. Ginsberg, and G. H. Guyatt MD,
"Incomplete Resection" in Non-Small Cell Lung Cancer: Need for a New Definition
Ann. Thorac. Surg., January 1, 1998; 65(1): 220 - 226.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The American Association for Thoracic Surgery.